1H3 Stock Overview
An investment holding company, provides healthcare solutions in Singapore, the Philippines, Hong Kong, Malaysia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Clearbridge Health Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$0.003 |
| 52 Week High | S$0.02 |
| 52 Week Low | S$0.003 |
| Beta | 0.59 |
| 11 Month Change | -62.50% |
| 3 Month Change | -66.67% |
| 1 Year Change | -75.00% |
| 33 Year Change | -97.44% |
| 5 Year Change | -97.83% |
| Change since IPO | -98.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1H3 | SG Healthcare | SG Market | |
|---|---|---|---|
| 7D | -25.0% | -0.5% | 0.007% |
| 1Y | -75.0% | -13.5% | 14.5% |
Return vs Industry: 1H3 underperformed the SG Healthcare industry which returned -13.5% over the past year.
Return vs Market: 1H3 underperformed the SG Market which returned 14.5% over the past year.
Price Volatility
| 1H3 volatility | |
|---|---|
| 1H3 Average Weekly Movement | 23.7% |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in SG Market | 14.8% |
| 10% least volatile stocks in SG Market | 2.2% |
Stable Share Price: 1H3's share price has been volatile over the past 3 months compared to the SG market.
Volatility Over Time: 1H3's weekly volatility (24%) has been stable over the past year, but is still higher than 75% of SG stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 121 | Jeremy Yee | www.clearbridgehealth.com |
Clearbridge Health Limited, an investment holding company, provides healthcare solutions in Singapore, the Philippines, Hong Kong, Malaysia, and internationally. It operates through Strategic Investments, Healthcare Systems, and Medical Clinics/Centres segments. The company provides imaging services, including general x-ray, computerized tomography scan, dental cone beam CT scan, mammography, magnetic resonance imaging, and ultrasound; general health services, such as diabetes, high blood pressure, and high cholesterol screening; and vaccination services, as well as renal care and clinical services.
Clearbridge Health Limited Fundamentals Summary
| 1H3 fundamental statistics | |
|---|---|
| Market cap | S$1.86m |
| Earnings (TTM) | -S$32.40m |
| Revenue (TTM) | S$9.89m |
0.2x
P/S Ratio-0.1x
P/E RatioIs 1H3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1H3 income statement (TTM) | |
|---|---|
| Revenue | S$9.89m |
| Cost of Revenue | S$5.17m |
| Gross Profit | S$4.72m |
| Other Expenses | S$37.12m |
| Earnings | -S$32.40m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.052 |
| Gross Margin | 47.71% |
| Net Profit Margin | -327.55% |
| Debt/Equity Ratio | 50.4% |
How did 1H3 perform over the long term?
See historical performance and comparison